Today’s news reports focus on four items:
- Development of aggressive prostate cancer from a single cell and tumor
- Prostate size and risk for positive surgical margins
- Quality of urinary function after different types of surgery
- Gefitinib as a single agent in treatment of CRPC … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: CRPC, development, gefitinib, origin, positive surgical margins, prostate size, surgery, urinary function | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 